Atlas Trials

A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Clinical trial NCT05156047 · COMPLETED

Trial details

NCT number
NCT05156047
Sponsor
Harmony Biosciences Management, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Hypersomnia
Start date
2022-05-25
Primary completion
2023-09-08
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.